Perceptive Advisors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$158,145,000
+64.2%
2,322,247
-23.0%
4.59%
+52.1%
Q2 2022$96,331,000
-28.6%
3,015,054
-22.5%
3.02%
+11.7%
Q1 2022$134,836,000
-33.2%
3,892,493
-43.6%
2.70%
+73.4%
Q4 2021$201,958,000
+79.8%
6,899,830
+56.6%
1.56%
-4.5%
Q3 2021$112,300,000
-61.4%
4,407,399
-46.9%
1.63%
-13.7%
Q2 2021$290,854,000
+41.1%
8,305,378
+64.2%
1.89%
-27.5%
Q1 2021$206,139,000
-16.1%
5,058,642
-10.9%
2.61%
-1.2%
Q4 2020$245,771,000
-23.2%
5,674,711
-2.2%
2.64%
-43.5%
Q3 2020$319,867,000
-13.3%
5,800,996
-0.7%
4.67%
-21.9%
Q2 2020$368,811,000
+19.0%
5,842,100
-3.7%
5.98%
-26.0%
Q1 2020$309,897,000
-33.5%
6,065,726
+3.4%
8.07%
-12.9%
Q4 2019$466,266,000
+63.6%
5,865,726
-0.2%
9.26%
+20.6%
Q3 2019$285,090,000
-6.2%
5,875,726
+1.7%
7.68%
+10.2%
Q2 2019$303,803,000
+3.9%
5,775,726
+4.5%
6.97%
-15.5%
Q1 2019$292,476,000
+31.3%
5,525,726
+1.8%
8.25%
-2.6%
Q4 2018$222,726,000
+13.8%
5,425,726
+5.4%
8.48%
+62.0%
Q3 2018$195,658,000
-10.4%
5,148,910
+6.6%
5.23%
-8.6%
Q2 2018$218,266,000
-9.4%
4,828,910
-3.2%
5.72%
-15.2%
Q1 2018$240,971,000
+25.3%
4,989,066
+2.0%
6.75%
+5.8%
Q4 2017$192,384,000
-27.3%
4,889,066
-42.7%
6.38%
+26.1%
Q3 2017$264,798,000
+146.1%
8,528,132
+116.8%
5.06%
-6.6%
Q2 2017$107,592,000
-24.3%
3,933,927
+1.9%
5.41%
-33.2%
Q1 2017$142,203,000
+214.5%
3,858,978
+23.3%
8.10%
+152.0%
Q4 2016$45,213,000
-16.0%
3,128,978
+34.1%
3.22%
-7.4%
Q3 2016$53,802,000
+46.9%
2,334,168
+5.7%
3.47%
+36.8%
Q2 2016$36,625,000
+78.0%
2,207,668
+70.2%
2.54%
+40.7%
Q1 2016$20,577,000
-46.4%
1,297,468
+9.3%
1.80%
-36.4%
Q4 2015$38,363,000
-50.6%
1,186,630
-35.6%
2.84%
-8.6%
Q3 2015$77,726,0001,843,6003.10%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders